The LINC01094 drives atherosclerosis endothelial injury and inflammation via the miR-218-5p/SP1 axis and servers as a clinical biomarker
LINC01094 is a promising biomarker for predicting AS. Moreover, silencing LINC01094 may decelerate AS progression via regulating the miR-218-5p/SP1 axis, thus alleviating endothelial injury and inflammation.
Authors
- Shuxia Yao
- Wenqi Yang
Institutions
- Jinzhou Medical University (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2026-03-07
- DOI
- https://doi.org/10.1186/s40001-026-04060-1
- Primary Topic
- Atherosclerosis and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00